ARTICLE | Company News
Lead Pharma Holding, Sanofi deal
February 23, 2015 8:00 AM UTC
The companies partnered to discover, develop and commercialize small molecule therapies against the RAR-related orphan receptor C thymus-specific isoform ( RORgamma2; RORgammaT) to treat autoimmune ...